Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
- PMID: 21782287
- DOI: 10.1016/j.neurobiolaging.2011.05.018
Structural MRI changes detectable up to ten years before clinical Alzheimer's disease
Abstract
Structural brain changes have been described in both mild cognitive impairment (MCI) and Alzheimer's disease (AD). However, less is known about whether structural changes are detectable earlier, in the asymptomatic phase. Using voxel-based morphometry (VBM) and shape analyses of magnetic resonance imaging (MRI) data, we investigated structural brain differences between groups of healthy subjects, stratified by subsequent diagnoses of MCI or AD during a 10-year follow-up. Images taken at baseline, at least 4 years before any cognitive symptoms, showed that subjects with future cognitive impairment (preclinical AD and MCI) had reduced brain volume in medial temporal lobes, posterior cingulate/precuneus, and orbitofrontal cortex, compared with matched subjects who remained cognitively healthy for 10 years (HC). For only those subjects later diagnosed as AD, significantly greater atrophy at baseline was detected in the right medial temporal lobe, which was also confirmed by shape analysis of the right hippocampus in these subjects. Our results demonstrate that structural brain changes occur years before clinical cognitive decline in AD and are localized to regions affected by AD neuropathology.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.Neuroimage. 2005 Oct 1;27(4):934-46. doi: 10.1016/j.neuroimage.2005.05.015. Neuroimage. 2005. PMID: 15979341
-
Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.Hippocampus. 2015 Aug;25(8):939-51. doi: 10.1002/hipo.22417. Epub 2015 Mar 26. Hippocampus. 2015. PMID: 25605659
-
Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.J Alzheimers Dis. 2015;45(1):253-68. doi: 10.3233/JAD-142451. J Alzheimers Dis. 2015. PMID: 25524955
-
[Quantitative magnetic resonance tomography in diagnosis of Alzheimer dementia].Z Gerontol Geriatr. 2001 Apr;34(2):101-7. doi: 10.1007/s003910170073. Z Gerontol Geriatr. 2001. PMID: 11393001 Review. German.
-
MRI morphometry in Alzheimer's disease.Ageing Res Rev. 2016 Sep;30:17-24. doi: 10.1016/j.arr.2016.01.003. Epub 2016 Jan 23. Ageing Res Rev. 2016. PMID: 26812213 Review.
Cited by
-
Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies.Methods Mol Biol. 2024;2785:143-162. doi: 10.1007/978-1-0716-3774-6_10. Methods Mol Biol. 2024. PMID: 38427193
-
3D convolutional neural networks uncover modality-specific brain-imaging predictors for Alzheimer's disease sub-scores.Brain Inform. 2024 Feb 4;11(1):5. doi: 10.1186/s40708-024-00218-x. Brain Inform. 2024. PMID: 38310619 Free PMC article.
-
Relationship between hippocampal subfield volumes and cognitive decline in healthy subjects.Front Aging Neurosci. 2023 Dec 7;15:1284619. doi: 10.3389/fnagi.2023.1284619. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38131011 Free PMC article.
-
Getting ahead of Alzheimer's disease: early intervention with focused ultrasound.Front Neurosci. 2023 Jul 27;17:1229683. doi: 10.3389/fnins.2023.1229683. eCollection 2023. Front Neurosci. 2023. PMID: 37575309 Free PMC article.
-
Identifying healthy individuals with Alzheimer's disease neuroimaging phenotypes in the UK Biobank.Commun Med (Lond). 2023 Jul 20;3(1):100. doi: 10.1038/s43856-023-00313-w. Commun Med (Lond). 2023. PMID: 37474615 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
